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ABSTRACT 
In this study, we investigate the potential for oral Lactobacilli (LB) to afford innate protection against nasopha- 
ryngeal coloniser Neisseria meningitidis serogroup B (NmB), which causes the bulk of UK meningococcal disease. 
Oral isolates of L. plantarum, L. salivarious, L. casei, L. rhamnosus, L. gasseri and gut probiotic L. rhamnosus GG 
were assessed for their ability to suppress nasopharyngeal epithelial inflammatory responses to pathogenic NmB. 
The specificity of attenuation was examined using TLR 2 ligand, Pam3Cys, and early response cytokine IL1β; 
and the mechanism of attenuation was explored using heat-killed organisms and conditioned medium. Pro-in- 
flammatory IL-6 and TNFα cytokine secretion was quantified by ELISA and associated cell death was quantified 
by PI staining and LDH release. NmB adhesion, invasion and metabolism were determined using standard gen- 
tamicin protection with viable counts, and bioluminescence, respectively. L. plantarum and L. salivarious sup- 
pressed IL-6 and TNFα secretions from NmB-infected epithelial cells. LB did not need to be alive and could sup- 
press using secretions, which were independent of TLR2 or IL1β receptor signalling. L. plantarum, in particular, 
reduced NmB-induced necrotic cell death of epithelial monolayers. Like L. salivarious, it significantly inhibited 
NmB adhesion but uniquely L. plantarum abolished NmB invasion. Using bioluminescence as a reporter of pa- 
thogen metabolism, L. plantarum and its secretions were found to inhibit NmB metabolism during cell invasion 
assays. We conclude that oral L. plantarum and its secretions could be used to help reduce the burden of menin- 
gococcal disease by removing the intracellular nasopharyngeal reservoir of NmB. 
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1. Introduction 
The Gram-negative bacterium Neisseria meningitidis 
(Nm) is one of the main etiologic agents of bacterial me- 
ningitis and septicaemia [1]. It is associated with a sig- 
nificant mortality and has a case fatality rate of 10% [2] 
reaching up to 55% in patients with fulminant septicae-  
mia [3]. Despite significant progress made in the man- 
agement of patients and the availability of vaccines 
against serogroups A, C, Y and W135, serogroup B 
(NmB) disease remains a major public health problem in 
the UK, Europe and the Australias, accounting for 85% - 
90% of meningococcal disease cases in the UK [4].  
Nasopharyngeal carriage of Nm has a population pre- 
valence of between 5% and 40%, with the highest rates *Corresponding author. 
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of carriage in teenagers, household contacts and military 
recruits [5,6]. In comparison to carriage, disease inci- 
dence is relatively rare. One of the factors associated 
with the relatively low disease prevalence is carriage of 
commensals, such as N. lactamica, in the nasopharyngeal 
mucosa [7,8]. In support of these studies, we have more 
recently shown that N. lactamica induces secretion of 
broadly protective innate IgM [9] and suppresses in- 
flammation during NmB infection of nasopharyngeal 
cells in vitro using a toll-like receptor 2 (TLR2)-depen- 
dent signalling mechanism [10].  
In addition to N. lactamica, other species of commen- 
sal lactic acid-producing bacteria have been isolated from 
the upper respiratory tract (URT) [11-15], including sev- 
eral Lactobacillus (LB) species [11,12,16,17]. Although 
some LB strains are reported to exhibit direct antimi- 
crobial properties against oral pathogens [11,12], no stu- 
dies to our knowledge have determined the protective in- 
fluence of oropharyngeal-derived LB isolates against pa- 
thogenic NmB. Studies on LB isolates from the gut [18] 
and urogenital tract [19-22], however, show that they can 
promote local barrier function and reduce inflammation 
[18-21], reduce N. gonnorhoea adhesion [22], E. coli K1 
invasion [23] and Group A streptococcal cytotoxicty [24]. 
In this study, we have evaluated for the first time the in- 
fluence of a panel of oropharyngeal-derived LB isolates, 
with known antimicrobial properties [11,12], and eva- 
luated their potential to afford innate immune protection 
to nasopharyngeal derived epithelial cells; against the na- 
sopharyngeal coloniser and Gram negative pathogen, 
NmB. 
2. Material & Methods 
2.1. Bacterial Isolates and Culture Conditions 
NmB strain MC58 was cultured from frozen stocks on 
HBHI agar and enumerated as previously [10]. LB were 
obtained from the National Collection of Industrial, Ma- 
rine and Food Bacteria (NCIMB) and include the oral 
isolates L. casei subsp.casei (NCIMB 8822), L. gasseri 
(NCIMB 8819), L. plantarum (NCIMB 8825), L. saliva- 
rius subsp. salivarius (NCIMB 11975), L. rhamnosus 
(NCIMB 6375) [11,16,25-27]; and the gastro-intestinal 
isolate L. rhamnosus GG [28]. LB strains were grown in 
MRS broth overnight in a shaking incubator at 37˚C. 
Bacteria were re-suspended in PBS-B (replete with cal- 
cium and magnesium) and infectious dose adjusted as 
required (OD 0.2 at 600 nm ≈ 2.5 × 107 cfu per ml). 
2.2. Nasopharyngeal Cell Line 
A human nasopharyngeal epithelial cell line, Detroit 562 
(ATCC CCL 138, ECACC 87042205), was grown as de- 
scribed elsewhere but in the absence of antibiotics [29]. 
Cells were used at 80% - 90% confluence and between 
passage numbers 3 to 10 in all experiments. 
2.3. Preparation of Heat Killed Bacteria and  
Pre-Conditioned Media 
Bacteria were inactivated by heating to 65˚C for 30 min 
in PBS-B. Inactivation was confirmed by overnight cul- 
ture in MRS broth and performing viable counts. Pre- 
conditioned media was generated from LB grown in 
complete assay medium (M199 + 2% FCS + HEPES) at 
37˚C for 6 h in the presence of Detroit 562 cells at the 
concentration of 200 bacteria/cell, or multiplicity of in- 
fection (MOI) 200. Bacteria were removed by centrifu- 
gation (15 min, 4000 × g) and the supernatant was steri- 
lized by filtration (0.2 μm), adjusted to pH 7.2 with 0.1 
M NaOH, and stored at −20˚C until use. 
2.4. Preparation of Bioluminescent N.  
meningitidis Strain MC58 
Plasmid pLKMP, described elsewhere [30], was used to 
Lux-transform NmB into a bioluminescent organism. In 
brief, spot overlay assays were performed with NmB 
overlaid onto a dried spot of plasmid DNA (1 µg) on 
HBHI agar, which was then incubated for 24 hours at 
37˚C and 5% CO2. Transformed bacteria were picked 
and subsequently re-selected using HBHI agar containing 
150 µg/mL kanamycin. The resultant bacterial isolates 
were confirmed to be NmB using colony morphology, 
gram-stain and differential biochemical tests. Lux-MC58 
was confirmed to have no growth advantage or disadvan- 
tage over wild-type MC58 by analysis of viable counts 
(cfu/ml) and optical density over time. Lux-MC58 was 
confirmed to have no adhesion or invasion advantage or 
disadvantage over wild-type MC58 by standard gentami- 
cin protection assay (not shown) [31]. 
2.5. Cytokine Induction Assays 
Cells (105 cells per well) were pre-incubated with live 
LB at a multiplicity of infection of 2-200 bacterial per 
cell (MOI 2, 20, 200), heat-killed LB (MOI 20) or condi- 
tioned media (0.1ppu or 10%) for 3 h and then challenged 
with NmB (MOI 200), TLR2 ligand PAM3Cys (100 
ng/mL), or early response cytokine IL-1β (10 ng/mL), for 
an additional 3 hrs at 37˚C and 5% CO2. Cells were wa- 
shed and cultured for a further 18 h in media containing 
gentamicin (200 µg/mL), supplemented with IL1-1β or 
Pam3Cys as required. Supernatants were filtered (0.2 µm) 
and stored at −80˚C until ready for testing by ELISA, as 
previously described [10]. 
2.6. Determination of Cytotoxicity 
Cell monolayers were pre-incubated with LB (MOI 2, 20, 
200) for 3 hrs and challenged with NmB (MOI 200) for 
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additional 3 hrs, as previously. Cells were washed and in- 
cubated in M199 containing gentamicin (at 200 µg/ml) 
but without phenol red for a further 18 h. Plates were 
centrifuged and supernatants collected for assessment of 
extracellular lactate dehydrogenase (LDH) activity, as a 
measure of cellular necrosis [32], according to the man- 
ufacturers’ instructions (Roche Applied Science, UK). 
Monolayers were then stained with 5 µg/mL propidium 
iodide [33] and read on a fluorescence microplate reader 
with excitation at 540 and emission at 620 nm (Fluostar 
Optima, BMG Labtech). Triton-X (0.1%) and Saponin 
(1%) were used as positive control treatments. Untreated 
cells were used as negative controls. 
2.7. Adhesion and Invasion—Standard  
Gentamicin Protection Assay 
The number of total cell-associated bacteria (adhesion 
and invasion) was determined using standard gentamicin 
protection assay [31]. In brief, confluent monolayers of 
Detroit 562 cells, were challenged with LB strains (MOI 
200) in M199 containing 2% FCS and incubated for 3 hrs 
in a humidified incubator at 37˚C and 5% CO2. Cells were 
then washed with Hanks balanced salt solution, lysed in 
1% saponin for 10 min, and plated on MRS agar to de- 
termine the total number of cell-associated LB bacteria. 
To enumerate the intracellular bacteria, cells were 
challenged for 3 h and incubated with gentamicin (200 
μg/mL) for 90 min to kill the extracellular bacteria prior 
to saponin treatment. The minimum inhibitory concen- 
tration of gentamicin for all isolates was previously con- 
firmed as less than or equal to 100 μg/mL. Controls were 
performed to determine the amount of bacterial growth 
during the 3 h assay and the amount of bacteria sticking 
to the side of the wells, which was then subtracted from 
adhesion and invasion values. Subtraction of the intra- 
cellular bacteria from the cell-associated bacteria gives 
the total number of adherent bacteria. 
To examine LB-induced protection against NmB ad- 
hesion and invasion, cells were pre-incubated for 3 h 
with L. plantarum or L. salivarious (MOI 200) prior to 
NmB challenge (MOI 200) for additional 3 h, as above, 
or co-incubated together for 3 h. Cells were treated with 
gentamicin and lysed in 1% saponin, as previously. NmB 
and LB were cultured on HBHI plates for 24 - 48 hrs at 
37˚C in 5% CO2 and colony counts were performed. 
Bacterial counts for LB were determined on MRS plates. 
These values were subtracted from total colony counts on 
HBHI plates to give NmB counts. Direct inhibition of me- 
ningococcal growth by LB on the HBHI plates was ruled 
out using standard spot-dilution assays. 
2.8. Bacterial metabolism—Bioluminescence  
Assay 
Using Lux-transformed NmB, we analysed the ability of 
L. plantarum, L. salivarious (MOI 20), heat-killed or- 
ganisms (MOI 20), or conditioned media (0.1 ppu) to 
inhibit light emission and thus metabolism of NmB (MOI 
200) over time [34]. A Floustar Optima (BMG Labtech) 
was used to record the light output and maintain the 
plates at 37˚C and in 5% CO2. 
NmB-Lux was used to examine the effect of LB on 
NmB metabolism in the presence and absence of cells. A 
standard gentamicin protection assay was performed, ex- 
cept that Detroit 562 cells were grown in 96-well black- 
sided tissue culture plates (Genetix). Cells were pre-treat- 
ed with LB (MOI 20), heat-killed LB (MOI 20) or condi- 
tioned media (0.1ppu) for 3 hrs prior to incubation with 
bioluminescent NmB (MOI 200). As previously, genta- 
micin was added 3 h after NmB-Lux to kill extracellular 
bacteria and 1% saponin was added at 4.5 h to allow kill- 
ing of the intracellular bacteria by the antibiotic. Differ- 
ences in light output pre- and 1.5 h post-saponin treat- 
ment were used to reflect the levels of metabolising in- 
tracellular NmB. 
2.9. Statistical Analysis 
For comparison of MC58 responses in the presence of 
increasing doses of each of the different LB strains (L. 
caseii, L. gasseri, L. plantarum, L. salivarious, L. rham- 
nosus, L. rhamnosus-GG) One-way ANOVA analysis of 
variance were performed. For comparison of MC58 res- 
ponses in the presence and absence of different LB 
strains (L. caseii, L. plantarum, L. salivarious), condition- 
ed media or heat-killed organisms (CM, HK) paired stu- 
dent t-tests were performed, with Bonferroni correction 
for multiple testing. All experiments were performed in 
at least three independent experiments and each of these 
was performed in triplicate. 
3. Results 
3.1. LB Show a Differential Ability to Attenuate  
Epithelial Inflammation in Nasopharyngeal  
Epithelial Cells 
NmB strain MC58 strongly induced IL-6 secretion (400 - 
500 pg/ml) and moderately induced TNF-α (20 pg/ml) 
from nasopharyngeal derived Detroit 562 epithelial cells 
(Figure 1). In contrast commensal LB strains (oral iso- 
lates L. casei subsp. Casei, L. gasseri, L. plantarum, L. 
salivarius subsp. Salivarius, L. rhamnosus and gut isolate 
L. rhamnosus GG) only weakly stimulated IL-6 (<10 
pg/ml) and TNF-α (5 - 10 pg/ml) secretion from these 
cells. Importantly oral L. plantarum and L. salivarius 
were able to attenuate NmB induced IL-6 and TNF-α du- 
ring co-culture by approximately 50% - 70% compared 
with NmB alone. Attenuation was apparent whether L. 
plantarum and L. salivarius were lower or equiva-  
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Figure 1. L. plantarum and L. salivarious attenuate NmB-induced IL-6 and TNF-α secretion. Detroit 562 nasopharyngeal cells 
were pre-incubated with Lactobacilli for 3 h (at a multiplicity of infection or moi of 2, 20, 200 bacteria per cell) and then chal- 
lenged for 3 h with NmB strain MC58 (at moi 200). Cells were washed and cultured for 21 h with antibiotics. Cytokines IL-6 
and TNF-α were quantified in cell culture supernatants by ELISA. Cells challenged with NmB (MC58) alone were compared 
with those pre-treated with Lactobacilli. The data represent mean values ±SEM from three independent experiments each 
performed in triplicate. *p < 0.05, **p < 0.01, ***p < 0.001. 
 
lent in concentration to NmB (*P < 0.05, **P < 0.01, ***P 
< 0.001). In contrast the gut-associated LB strain L. 
rhamnosus GG and oral strain L. rhamnosus were unable 
to attenuate IL-6 and TNF-α response in NmB-infected 
nasopharyngeal epithelial cells. Modest reductions were 
demonstrated with oral strains L. casei and L. gasseri 
these were not statistically significant. 
3.2. Conditioned Media from L. plantarum and L. 
salivarius Are Sufficient to Attenuate  
NmB-Induced Inflammation 
Heat-killed (HK) L. casei, L. plantarum and L. salivarius 
significantly attenuated IL-6 responses induced by NmB 
(Figure 2), albeit to differing degrees (20%, P < 0.01 – 
60%, P < 0.05), demonstrating that LB viability is not 
essential for attenuation of inflammation by these spp. 
Conditioned media (CM) containing secretions from live 
L. plantarum and L. salivarius but not L. casei were also 
found to strongly attenuate the IL-6 response induced by 
NmB by 42% (P < 0.001) - 62% (P < 0.05), which we 
suggest contributes to the strong ability of these strains to 
attenuate in live co-cultures. 
3.3. Live and Heat Killed LB Strains but Not  
LB-Conditioned Media Are Able to  
Attenuate Inflammation Induced via TLR-2 
The specificity of the observed anti-inflammatory effect 
was further evaluated by stimulating cells with the TLR- 
2 ligand Pam3Cys (100 ng/ml) in the presence and ab- 
sence of LB. There was a marked reduction (60% - 75%) 
in secretion of IL-6 when cells were treated with live L. 
plantarum (P < 0.001), L. salivarius (P < 0.01) or L. ca- 
sei (P < 0.01) prior to stimulation with Pam3Cys (Figure 3) 
but not when treated with the early response cytokine 
IL-1β (10 ng/ml) (not shown). Significant IL-6 attenua- 
tion was also evident from Pam3Cys-stimulated cells 
when co-cultured with heat-killed L. plantarum or L. sa- 
livarius (P < 0.05) but not with L. casei, or conditioned 
media from either organism (changes were non-signifi- 
cant), suggesting that conditioned medium from L. plan- 
tarum or L. salivarius attenuates inflammation through a 
TLR-2 independent mechanism. 
3.4. LB Strains Are Able to Inhibit  
NmB-Induced Necrotic Cell Death 
NmB is cytotoxic to epithelial cells [35] and has been  
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Figure 2. Heat-killed LB and conditioned media from L. plantarum and L. salivarious also attenuate NmB-induced inflamma- 
tion. Detroit 562 cells were pre-incubated with heat-killed Lactobacilli (HK, moi-20), or conditioned media, (CM, 0.1 part per 
unit in M199 with 2% FCS, pH = 7.2) and challenged with NmB strain MC58 (moi 200). IL-6 was quantified in cell culture 
supernatants by ELISA. Cytokine levels from cells challenged with NmB alone were compared with those pre-treated with 
Lactobacilli. The data represent mean values ±SEM from three independent experiments each performed in triplicate. *p < 
0.05, **p < 0.01, ***p < 0.001. 
 
 
Figure 3. Live LB but not LB conditioned media attenuate inflammation induced through TLR-2 receptor. Detroit 562 cells 
pre-treated with live LB, heat killed LB (moi-20), or conditioned media (0.1 ppu) for 3 hrs prior to challenge with the TLR2 
ligand Pam3Cys (100 ng/ml), or IL1β (10 ng/ml). Cytokines were quantified from supernatants generated over 21 h of culture 
using ELISA. Cytokine levels from cells challenged with Pam3Cys or IL1β alone were compared with those pre-treated with 
LB. The data represent mean values ±SEM from three independent experiments each performed in triplicate (*p < 0.05, **p < 
0.01, ***p < 0.001). 
 
reported to induce cell necrosis in other cell types [36], 
which is associated with induction of inflammation and 
weakening of the mucosal barrier function. We therefore 
examined nasopharyngeal epithelial cells for necrotic cell 
death in response to NmB infection and potential cyto- 
protection afforded by LB. NmB induced a low but sig- 
nificant level of necrotic cell death in Detroit 562 mono- 
layers following 3 h challenge and 21 h culture, which was 
NmB dose dependent (P < 0.001) (Figure 4), and equiv- 
alent to death of approximately 5% - 8% of cells. LB 
strains alone were not cytotoxic to these cells (data not 
shown). Culture of cells with NmB in the presence of L. 
plantarum, L. salivarius or L. casei, however, led to a 
significant reduction in NmB-induced necrosis, as deter-   
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Figure 4. LB strains, particularly L. plantarum, inhibit NmB-induced necrotic cell death. Detroit 562 cells were pre-incubated 
with Lactobacilli (at moi-200) before co-incubation with a range of NmB doses (moi 2, 20, 200, 2000). Cytotoxicity was meas- 
ured by propidium iodide staining of cells in situ after 24 hr culture and staining intensity was quantified by plate reader 
giving values in mean fluorescence units (MFU). The enzyme activity of cytosolic lactate dehyrogenase was also quantified 
from cell culture supernatants and expressed as a percentage of the positive control value to give percentage cytotoxicity. The 
data represent mean values ±SEM from three independent experiments each performed in triplicate (*p < 0.05). Triton-X 
treated cells were used as a positive control. 
 
mined by propidium iodide staining (P < 0.05). Using 
lactate dehydrogenase enzyme release as an alternative 
and more direct measure of cell necrosis, only L. planta- 
rum was significantly able to reduce necrotic cell death 
in nasopharyngeal derived epithelial cells challenged with 
NmB (P < 0.05). 
3.5. L. plantarum Inhibits Adhesion to and  
Invasion of Nasopharyngeal Epithelial Cells  
by NmB 
We postulated that the differential protection afforded by 
LB strains may be related to their ability to adhere to na- 
sopharyngeal epithelial cells and interfere with the adhe-
sion and invasion of NmB. Using standard gentamicin 
protection and viable counts [31] we demonstrated that 
LB isolates, including the gut isolate L. rhamnosus GG, 
were readily able to adhere to Detroit 562 epithelial cells 
at levels of approximately 1 to 2 bacteria per cell, or 1% 
of inoculum (Figure 5(a), grey fill). In comparison L. 
salivarius and L. rhamnosus were roughly 10 fold less 
adherent and L. rhamnosus, in particular, was less able to 
grow in culture medium over the period of the experi- 
ment than the other isolates (Figure 5(a), black fill). 
Only L. casei, L. rhamnosus GG and L. plantarum were 
found to invade nasopharyngeal epithelial cells, albeit to 
variable degrees (equivalent to 1.68, 0.86 and 15 per 
1000 epithelial cells, respectively) (Figure 5(a), white 
fill).  
In contrast to LB, NmB demonstrated adhesion levels 
of approximately 10 bacteria per cell (10% - 20% of in- 
oculum) and invasion levels of 2 bacteria per 100 cells, 
similar to L. plantarum (Figure 5(b), black fill). Co- in- 
cubation of cells with L. plantarum (MC58 + L. plan- ta- 
rum) or L. salivarius (MC58 + L. salivarious) reduced 
NmB adhesion to Detroit 562 cells by 65% and 87% re- 
spectively (Figure 5(b) and c, grey fill). L. plantarum 
inhibited recovery of live intracellular NmB by 93% 
(Figure 5(b), grey fill), where as L. salivarious inhibited 
recovery by 65% (Figure 5(c), grey fill). In bacteria only 
controls, NmB growth was also reduced by 43% in the 
presence of L. plantarum but not L. salivarious (not 
shown). 
3.6. L. plantarum, L. salivarius and Conditioned  
Media from L. plantarum Inhibit NmB  
Metabolism 
The influence of L. plantarum and L. salivarius on NmB 
was further explored using Lux-transformed NmB, which  
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Figure 5. L. plantarum and L. salivarious inhibit NmB adhesion and invasion of nasopharyngeal epithelium. (a) The ability of 
the different LB strains to adhere and invade nasopharyngeal epithelial cells was determined using standard gentamicin pro- 
tection assay and viable counts. Monolayers of Detroit 562 cells were incubated with each LB strain (moi 200) for 3 hrs. The 
dotted line represents the limit of detection of the assay. Data represent means ±SEM from three independent experiments, 
each performed in triplicate. (b) The number of NmB adhering and invading epithelial cells in the presence (grey fill) and 
absence of L. plantarum (black fill). (c) The number of NmB adhering and invading epithelial cells in the presence (grey fill) 
and absence of L. salivarious (black fill). In (b) and (c) Detroit 562 cells were pre-incubated with LB for 3 h (moi 200) and 
challenged for a further 3 h with NmB (moi 200). Data represent means of two independent experiments each performed in 
triplicate. 
 
emits light in the visible spectrum and is a highly sensi- 
tive reporter of bacterial metabolism that can be moni- 
tored in real-time [34]. In bacteria only controls, light 
output from NmB-Lux was reduced to background levels 
within 3 - 6 hrs of co-culture with live L. plantarum or L. 
salivarius (Figures 6(a) and (b), P < 0.001, open circles). 
Conditioned media from L. plantarum reduced light out- 
put, by 60% within an hour (P < 0.05) and maintained 
this level of reduction over the 12 h time course of study 
(Figure 6(a), inverted triangles). In contrast no reduction 
in NmB-Lux light output was observed with heat-killed 
L. plantarum (closed squares), heat-killed L. salivarius 
(Figure 6(b), closed squares) or conditioned media from 
L. salivarius (Figure 6(b), inverted triangles). 
3.7. L. plantarum and Conditioned Media Inhibit  
the Detection of Metabolising Intracellular  
NmB 
Crucially we next examined the effects of LB on NmB 
metabolism during host epithelial cell invasion, using a 
standard gentamicin protection assay [31] but measuring 
light output rather than viable counts [34]. Cells were in- 
cubated with bioluminescent NmB for 3 h then treated 
with gentamicin to kill the extracellular bacteria, so that 
the light remaining represents metabolising bacteria that 
have invaded the epithelial cells. Light output from intra- 
cellular NmB was almost completely absent in the cells 
pre-incubated with live L. plantarum compared to cells  
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Figure 6. L. plantarum and its conditioned media inhibits NmB metabolism directly and during epithelial cell invasion. (a) 
The direct effect of live L. plantarum (moi 200), heat-killed (HK) or conditioned media (CM, 0.1ppu) on NmB metabolism 
(moi 200) was determined in microbial co-cultures by measuring light output from MC58 lux+ over time. (b) The effects of L. 
salivarius (live, HK, CM) on NmB was similarly determined and representative experiments are shown. (c) The effects of L. 
plantarum, HK and CM on NmB metabolism during epithelial cell invasion were determined using a standard gentamicin 
protection assay but measuring light output from MC58 lux+ as the endpoint. Epithelial cells were pre-incubated with L. 
plantarum, HK or CM and challenged 3h later with NmB lux+. (d) Cells were pre-incubated with live L. salivarius, HK, or 
CM, and challenged with NmB as above. Data for (c) and (d) represent means of three independent experiments each per- 
formed in triplicate (*P < 0.05, ***P < 0.001). 
 
treated with NmB alone (Figure 6(c), P < 0.001), mir-
roring results from the gentamicin protection assay. Us-
ing this more sensitive assay, a significant reduction in 
light output was also observed (60%) when cells were pre- 
treated with conditioned medium from L. plantarum (P < 
0.05) but no reduction was afforded by pre-incubation 
with heat-killed L. plantarum. Live L. salivarious reduc- 
ed light output by approximately 40%, again mirroring 
results from the standard gentamicin protection assay. In 
contrast, neither heat-killed L. salivarious, nor condition- 
ed media from L. salivarious, was able to significantly 
reduce intracellular NmB light output (Figure 6(d)). 
4. Discussion 
4.1. Rationale for Study Design 
In this study we describe for the first time how oropha- 
ryngeal isolates of LB differentially affect innate immune 
responses at the nasopharyngeal epithelium and afford 
protection against an important URT pathogen, NmB.  
Five oropharyngeal isolates (L. salivarious, L. casei, L. 
plantarum, L. rhamnosus, L. gasseri) were selected for 
their antimicrobial activity against oral pathogens in other 
studies [11], whilst the well-studied gut probiotic L. rham- 
nosus GG [28], which has been reported to protect against 
inflammatory colitis [37,38], was selected for initial com- 
parison. 
4.2. Inflammation 
Our results highlight that, in contrast to gut derived L. 
rhamnosus GG, oropharyngeal isolates LB can signifi- 
cantly protect nasopharyngeal derived epithelium from 
excessive IL-6 release during NmB infection (Figure 1). 
Like other commensals [10] LB were able to attenuate 
inflammation mediated through TLR-2 receptor on na- 
sopharyngeal epithelial cells (Figure 3, not all shown), 
as in other tissues [39]. Only L. plantarum and L. saliva- 
rious, however, were able to significantly attenuate both 
IL-6 and TNF-α responses (Figure 1) and none of the LB  
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was able to attenuate responses to the early response pro- 
inflammatory cytokine IL1-β. These results highlight a 
strain and stimulus-dependent protection by LB, which 
we suggest is enhanced for L. plantarum and L. saliva- 
rious against NmB by a factor secreted in their condi- 
tioned medium (Figure 2). In our study inflammatory at- 
tenuation by their conditioned medium was largely inde- 
pendent of TLR-2 (Figure 3), in contrast to others [40], 
so is unlikely to involve LB lipoteichoic acid, which can 
be shed in vesicles by some strains [41] and is highly an- 
ti-inflammatory [42,43]. 
4.3. Cell Death 
The immune system is thought to be activated by tissue 
damage via the release of danger signals [44]. As such, 
inflammatory cytokine secretion can be triggered by cell 
death, in particular necrosis, which causes the release of 
intracellular nucleic acid, uric acid and heat shock pro- 
teins. We therefore examined the possibility that our anti- 
inflammatory LB strains, L. plantarum and L. salivarious, 
may afford protection against known NmB-induced cy- 
totoxicity [35,45]. All LB strains (Figure 4, not all 
shown), however, were able to abrogate NmB-induced 
cytotoxicity, as reported for other pathogens [24,46-48], 
suggesting LB protection against pathogen cytotoxicity is 
not directly linked to inflammatory attenuation. Using 
LDH enzyme activity as a more specific measure of ne- 
crotic cell death, only L. plantarum significantly reduced 
NmB cytotoxicity. In our study this associated with re- 
duced pathogen adhesion (Figure 5), as suggested else- 
where [22,48,49] but most clearly associated with pro- 
tection against NmB invasion (Figure 5) or intracellular 
survival (Figure 6). 
4.4. Adhesion 
Despite the differential ability of our LB strains to pro- 
tect nasopharyngeal cells from NmB-induced inflamma- 
tion and cytotoxicity, they were all well able to adhere to 
Detroit 562 cells, as to other respiratory cell lines [13,14]. 
We observed 65% - 87% reduction in NmB adhesion to 
nasopharyngeal cells by co-culturing with L. plantarum 
or L. salivarious (Figures 5(b) and (c)) but found that 
there were 10 fold fewer LB adhering than NmB, sug- 
gesting direct competition for host receptors used for 
bacterial adhesion is unlikely to account for it. It is poss- 
ible that L. plantarum and L. salivarious secrete surface 
associated inhibitory proteins to reduce adhesion [22, 
49] which is consistent with their secretions reducing 
NmBinduced inflammation (Figure 2) and invasion 
(Figure 6(c)). It is also possible that the dramatic inhibi- 
tion of NmB metabolism by L. plantarum and L. saliva- 
rious in planktonic culture (Figure 6(a)) may reduce 
NmB virulence prior to adhesion. NmB growth was also 
inhibited by L. plantarum but only in planktonic culture. 
It was not observed in agar overlays, in contrast to other 
studies of intestinal pathogens [50] and Neisseria gon- 
norhoea [51], suggesting phase-dependent inhibition of 
NmB. 
4.5. Invasion 
Crucially L. plantarum abrogated NmB invasion (Figure 5), 
or recovery of viable intracellular NmB from nasopha- 
ryngeal epithelial cells (Figure 6(c)). L. plantarum was 
equally invasive as NmB (15 - 20 bacteria per cell), sug-
gesting that they may compete for host receptors used for 
bacterial invasion [22,52]. Studies on E. coli suggest that 
L. plantarum could induce changes in epithelial cells to 
indirectly reduce pathogen association, through ERK 
phosphorylation [53]. In our study, however, L. planta- 
rum uniquely inhibited encapsulated NmB metabolism 
using secretory factors (Figure 6(a)), including during 
epithelial cell invasion (Figure 6(c)). Further studies are 
needed to investigate the mechanism but suggest that se- 
cretions from L. plantarum may be used to protect against 
NmB invasion and survival within the nasopharynx. 
5. Limitations 
There are a number of limitations to our study including 
the fact that gentamicin protection may reflect bacteria 
that are intimately associated with the host cell [54], 
which precedes invasion, rather than invasion itself. Use 
of saponin however demonstrated that an intracellular 
pool of bacteria were present. In this study we used a cell 
line which may not reflect responses in primary cells [55]. 
This cell line is however well-characterised [10] and ex- 
presses all the relevant receptors for Neisserial interac- 
tion [55]. We also used a representative strain of NmB 
(MC58) which may not reflect the response of all NmB 
isolates. However its genome has been fully sequenced 
[56] and it is highly adhesive and invasive (Figure 5) 
and thus stringently tested our hypothesis. We cannot 
rule out the possibility that Lux-transformation altered 
NmB metabolic behaviour, however growth kinetics of 
the parent and Lux-variants were found to be the same, 
and results for standard gentamicin protection assay and 
viable counts were comparable for Lux-MC58 and MC58 
(not shown). 
6. Conclusions 
Taken together we present strong evidence for protection 
of nasopharyngeal epithelial cells against NmB induced 
pathogenicity by commensal L. plantarum. We find, 
however, that not all LBs are equal with regard to their 
probiotic potential in the nasopharynx. Caution should 
therefore be used when assessing the efficacy of probio- 
tics (reviewed by Hao and colleagues [57]), as protection  
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shows strain and pathogen specific. We show that oral 
LB species, in particular L. plantarum, may be used as a 
means of providing broad prophylactic mucosal protec- 
tion against the invasive upper respiratory pathogen NmB, 
through reduced host cell inflammation and cytotoxicity, 
plus pathogen adhesion, invasion and metabolism. This 
ability may have developed during coevolution of L. plan- 
tarum and Nm, which commonly colonise the same niche. 
Further studies are needed but suggest that secretions 
from L. plantarum can protect against highly invasive and 
fully encapsulated NmB and prevent its invasion and sur- 
vival within nasopharyngeal epithelium. The latter could 
remove the NmB mucosal reservoir and thus help reduce 
transmission, septicaemia and meningitis. 
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